Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation
Fang Lyu, Chase Burzynski, Yuan yuan Fang, Aya Tal, Alice Y. Chen, Jacqueline Kisa, Kriti Agrawal, Yuval Kluger, Hugh S. Taylor, Reshef Tal
Fang Lyu, Chase Burzynski, Yuan yuan Fang, Aya Tal, Alice Y. Chen, Jacqueline Kisa, Kriti Agrawal, Yuval Kluger, Hugh S. Taylor, Reshef Tal
View: Text | PDF
Research Article Reproductive biology

Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation

  • Text
  • PDF
Abstract

CXCR4 is a key regulator of the development of NK cells and DCs, both of which play an important role in early placental development and immune tolerance at the maternal-fetal interface. However, the role of CXCR4 in pregnancy is not well understood. Our study demonstrates that adult-induced global genetic CXCR4 deletion, but not uterine-specific CXCR4 deletion, was associated with increased pregnancy resorptions and decreased litter size. CXCR4-deficient mice had decreased NK cells and increased granulocytes in the decidua, along with increased leukocyte numbers in peripheral blood. We found that CXCR4-deficient mice had abnormal decidual NK cell aggregates and NK cell infiltration into trophoblast areas beyond the giant cell layer. This was associated with low NK cell expression of granzyme B, a NK cell granule effector, indicative of NK cell dysfunction. Pregnancy failure in these mice was associated with abnormalities in placental vascular development and increased placental expression of inflammatory genes. Importantly, adoptive BM transfer of WT CXCR4+ BM cells into CXCR4-deficient mice rescued the reproductive deficits by normalizing NK cell function and mediating normal placental vascular development. Collectively, our study found an important role for maternal CXCR4 expression in immune cell function, placental development, and pregnancy maintenance.

Authors

Fang Lyu, Chase Burzynski, Yuan yuan Fang, Aya Tal, Alice Y. Chen, Jacqueline Kisa, Kriti Agrawal, Yuval Kluger, Hugh S. Taylor, Reshef Tal

×

Figure 1

Increased resorptions and reduced litter size in CXCR4 knockout mice.

Options: View larger image (or click on image) Download as PowerPoint
Increased resorptions and reduced litter size in CXCR4 knockout mice.
(A...
(A) Transgenic tamoxifen-inducible Cre+ (CAG-Cre-ESR1) mice homozygous for the floxed CXCR4 gene were created. Upon tamoxifen administration, Cre recombinase translocates to the nucleus where it excises exon 2 of the CXCR4 gene. Cre+CXCR4fl/fl and Cre–CXCR4fl/fl female mice were injected with tamoxifen (75 mg/kg) over 5 days to induce Cre recombination. Following tamoxifen, Cre+CXCR4fl/fl mice and Cre–CXCR4fl/fl mice are designated CXCR4 KO and WT, respectively. Following a 14-day washout period, females were mated with WT males. Mice were euthanized between E9.5 and E12.5, and implantation sites were extracted for downstream analyses, or between E13.5 and E18.5 for analysis of implantation sites and resorptions. Another cohort was followed for litter size and newborn weights. (B) CXCR4 relative mRNA expression (RT-PCR) in peripheral blood and decidua of WT and KO mice. n = 10–11/ group. (C) Resorption rate per pregnancy (%) for WT and KO mice. n = 8–11/group. (D) Percentage of dams with resorptions in WT and KO mice. (E) Total number of implantation sites per pregnant mouse in WT and KO mice. n = 15–16/group. (F) Representative images of implantation sites in WT and KO mice showing resorptions (red arrows) in KO mice. (G) Litter size of WT and KO mice (n = 15–16/group). (H) Kaplan-Meier curve showing the time (days) from beginning of mating to delivery for WT and KO mice. (I) Mean neonatal birth weight/litter (grams) for WT and KO mice. n = 15–16 litters/group. (J) Ratio of embryo/placenta weight from E13.5 to E18.5 for WT and KO mice. Data shown are means of the mean embryo/placenta ratios of each pregnant dam. n = 15–16 mice/group. *P < 0.05; **P < 0.01; ***P < 0.001 by 2-tailed Student’s t test for comparisons between 2 groups. Graphical data are shown as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts